KIORA PHARMACEUTICALS INC
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors (the “Board”) of EyeGate Pharmaceuticals, Inc. (the “Company”), effective immediately.
On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors (the “Board”) of EyeGate Pharmaceuticals, Inc. (the “Company”), effective immediately.
Extracted from this filing and checked against the source text.
Steven Boyd resigned as Director at KIORA PHARMACEUTICALS INC.
On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors (the “Board”) of EyeGate Pharmaceuticals, Inc. (the “Company”), effective immediately.View on SEC.gov
I. Keith Maher, MD resigned as Director at KIORA PHARMACEUTICALS INC.
On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors (the “Board”) of EyeGate Pharmaceuticals, Inc. (the “Company”), effective immediately.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.